through combinatorial associations with accessory factors.
ies. Sequences that did not correspond to known genes attachment regions (SARs/MARs), Acinus, a caspase-3-activated protein required for apoptotic chromatin conwere then used as probes for in situ hybridization to E9.5 mouse embryos and for Northern blot analysis of densation, and PIAS, an inhibitor of STAT-mediated gene activation. The SAP domain is a 35 amino acid motif adult mouse tissues, in order to further confirm their possible cardiac-specific expression. One of the cDNAs containing two predicted amphipathic helices separated by an intervening region with an invariant glycine resiidentified in this screen corresponded to a 3Ј untranslated region, which we used to isolate full-length cDNAs.
due. The two helices, which contain several highly conserved positively charged residues, have been predicted The extended cDNA sequence encoded a novel protein of 807 amino acids ( Figure 1A ), which we named myocarto resemble helices-1 and -2 of the homeodomain (Kipp et al., 2000). However, SAP domain proteins do not condin because of its specific expression in the adult myocardium and its essential role in myocardial gene extain a third helix as is found in homeodomain proteins.
Myocardin does not show homology to other known pression in vivo.
Myocardin contains a SAP domain ( Figure 1B ), found proteins outside of the SAP domain. However, we identified additional mouse, human, and Drosophila sein a variety of proteins that influence nuclear architecture and transcription (reviewed in Aravind and Koonin, quences encoding proteins with homology to the SAP and basic domains of myocardin ( Figure 1B ). 2000). Other notable features of myocardin include a basic region, an extended amphipathic ␣ helix resembling a leucine zipper, and a stretch of glutamine (Q) residues ( Figure 1A) .
Myocardin Is Highly Expressed in Developing Cardiac and Smooth Muscle The SAP domain is named for the nuclear scaffold attachment factors A and B (SAF-A and -B), which recog-
Northern blot analysis of adult mouse tissues revealed multiple myocardin transcripts specifically in adult heart. nize chromosomal regions known as scaffold or matrix There was no detectable expression of myocardin in fusing it to the DNA binding domain of yeast GAL4. As shown in Figure 3B , myocardin fused to the GAL4 DNA any other adult tissue examined (Figure 2A) .
In situ hybridization to staged mouse embryos binding domain potently activated a GAL4-dependent reporter in transfected COS cells. Residues 50-537 or showed that myocardin transcripts were first detected in the cardiac crescent at E7.75 ( Figure 2B, a) , concomitant portions of this region showed no transcriptional activity in this assay, whereas the region from residues 541-807 with expression of the homeobox gene Nkx2.5, the earliest known marker for cardiogenic specification (Lints et  was that compete for activation through the GAL4 DNA binding site. Further carboxy-terminal deletions resulted in Myocardin is also expressed in a subset of embryonic vascular and visceral smooth muscle cells. At E13.5, diminished transcriptional activity, suggesting that the activation domain is distributed over a relatively exmyocardin expression was evident within smooth muscle cells lining the walls of the esophagus and aortic tended region. arch arteries, as well as the pulmonary outflow tract ( Figure 2B, f and g ). Expression in these smooth muscle Myocardin Activates Transcription through cell types was still apparent, but was diminished, by SRF Binding Sites E15.5 (data not shown). Myocardin expression was also To identify potential target genes for myocardin, we detected in smooth muscle cells within the lung and gut tested a series of cardiac muscle gene regulatory re-( Figure 2B , f and h), as well as in head mesenchyme gions linked to a luciferase reporter for their respon-( Figure 2B, d) , which may serve as a source of smooth siveness to myocardin in transfected COS cells. Myocarmuscle precursors. Myocardin was not expressed at din strongly transactivated the promoters for the SM22, detectable levels in skeletal muscle.
atrial natriuretic factor (ANF), myosin light chain (MLC)-2V, and ␣-MHC genes, as well as the enhancer for the Nkx2.5 gene ( Figure 4A ). In contrast, myocardin failed Myocardin Is a Highly Potent Transactivator As a first step toward determining the function of myoto activate the HRT2 promoter or the dHAND enhancer, which are active in subsets of cardiac muscle cells. The cardin, we examined the subcellular distribution of the protein in transfected COS cells. Myocardin protein was cytomegalovirus (CMV) or E1b promoters, which show no tissue specificity, also were not activated by myocarlocalized predominantly to the nucleus and showed a punctate intranuclear staining pattern with exclusion din, indicating that myocardin does not act as a general transcriptional activator. from nucleoli ( Figure 3A) .
Because myocardin was localized to the nucleus, we The SM22 promoter was the most responsive to myocardin, being upregulated by several thousand-fold. tested whether it possessed transcriptional activity by SM22 encodes a troponin-related protein expressed in myocardin, whereas SRF was only able to activate expression by 8-fold ( Figure 4C ). Together, these results developing cardiac, smooth, and skeletal muscle cells during early embryogenesis, before becoming restricted demonstrate that myocardin is a much more potent transactivator than SRF, and that myocardin acts preferspecifically to the smooth muscle lineage (Li et al., 1996). Transcription of SM22 in cardiac and smooth muscle entially through multiple CArG boxes. As shown in Figure 4D , myocardin was extremely cells in vivo is dependent on two CArG boxes in the promoter, referred to as CArG-near (at Ϫ150/Ϫ141) and sensitive to the level of SRF, such that at low concentrations of SRF expression plasmid, myocardin and SRF CArG-far (at Ϫ273/Ϫ264), that bind SRF (Li et al., 1997; Kim et al., 1997). Although these sites are essential for synergistically activated SM22 transcription, whereas at higher concentrations of SRF, transcriptional activa-SM22 transcription, SRF transactivates the SM22 promoter only about 10-fold in nonmuscle cells, suggesting tion by myocardin was reduced. Inhibition of myocardindependent transcription by excess SRF could be rethat an additional SRF cofactor may be required for full activity of the SM22 promoter in muscle cells.
lieved by increasing the amount of myocardin. We conclude from these results that the ratio of SRF to To investigate the potential requirement of the SM22 CArG boxes for responsiveness to myocardin, we tested myocardin is important for transcriptional activation by myocardin, and that exceeding an optimal ratio with whether mutations in either CArG box in the context of the 1343 bp promoter impaired responsiveness to an excess of SRF results in attenuation of myocardin activity. myocardin. Mutation of the distal CArG box (CArG-far) reduced responsiveness to myocardin by 5-fold, but this mutant promoter was still activated several hundredDomain Mapping of Myocardin To further define the mechanism for myocardin-depenfold. In contrast, mutation of the proximal CArG box (CArGnear) almost completely eliminated the ability to respond dent transcription, we analyzed the transcriptional activity of a series of amino-and carboxy-terminal deletion to myocardin, and mutation of both CArG boxes completely abolished activation by myocardin ( Figure 4B ). mutants ( Figure 5A ). Deletion of the first 66 residues (mutant N⌬66) did not impair transcriptional activity of The ANF promoter also contains two CArG boxes that are required for transcriptional activity in cardiomyomyocardin with either the SM22 or ANF promoters. In contrast, further amino-terminal deletion to residue 140 cytes (Hines et al., 1999). As with the SM22 promoter, mutation of the distal CArG box severely reduced activa-(mutant N⌬140), which eliminates the basic region, resulted in a complete loss in transcriptional activity. The tion by myocardin, and a promoter with both CArG boxes mutated was unable to respond to myocardin (Figure loss in activity of this mutant appears to be due to deletion of the basic region because an internal deletion 4B). In contrast to the extreme sensitivity of the SM22 and ANF promoters to myocardin, the c-fos promoter, mutant (⌬basic) lacking only the basic region was also unable to activate transcription. All further N-terminal which contains a single essential CArG box (Gilman et al., 1986), was not activated by myocardin ( Figure 4A ). deletions up to amino acid 615, as well as an internal deletion of the Q-rich domain (mutant ⌬Q), also elimiTo determine whether the CArG box was sufficient to confer transcriptional responsiveness to myocardin, we nated transcriptional activity ( Figure 5A ). Deletion of residues 585-807 (mutant C⌬585) or 381-tested whether myocardin could transactivate reporter genes containing four tandem copies of SM22 CArG-807 (C⌬381) also abolished all transcriptional activity. These results are consistent with the results of GAL4 near or the c-fos SRE linked to the E1b promoter. These reporters were transactivated several hundred-fold by fusions, which indicated the existence of a transcription activation domain between residues 541 and the cardependent promoters. The basic region also appears to be required for nuclear localization since deletion of this boxyl terminus. Interestingly, when coexpressed with full-length myocardin, these carboxy-terminal deletion region resulted in relocalization of myocardin from the nucleus to the cytoplasm (data not shown). mutants acted in a dominant negative manner and severely impaired the ability of the wild-type protein to
We examined the functional importance of the SAP domain by introducing proline mutations into helix-1 or activate the SM22 ( Figure 5B ) and ANF promoters (data not shown).
-2 (mutants PSF and PGH). These mutations had only a modest effect on the ability of myocardin to transactiTo determine whether the transactivation domain conferred specificity to myocardin, we fused the viral coactivate the SM22 promoter, but they abolished activation of the ANF promoter. Similarly, deletion of the linker vator protein VP16 to the carboxy-terminal deletion mutants that were transcriptionally inactive. As shown in region between the two helices of the SAP domain, shown previously to be required for DNA binding by tested whether myocardin translated in vitro could bind supershifted by antibodies against SRF or FLAG-tagged myocardin. The total amount of SRF DNA binding was to the CArG boxes from the SM22 promoter. SRF bound to both CArG boxes, but no binding of myocardin to comparable in the presence and absence of myocardin, suggesting that association of SRF with myocardin does either CArG box was detectable in gel mobility shift assays. However, myocardin in the presence of SRF not alter the affinity of SRF for the CArG box. Myocardin and SRF also formed a ternary complex with the c-fos gave rise to a prominent ternary complex with the CArG box sequence (Figure 6A ). This ternary complex was and ANF CArG boxes, the intensity of which correlated directly with the relative binding of SRF to the site (data interpretation that the amino terminus of myocardin confers transcriptional specificity by mediating association not shown). The lack of obvious homology in the flanking sequences of these different CArG boxes suggests that with SRF, whereas the carboxyl terminus activates transcription. myocardin associates directly with SRF and does not depend on specific DNA sequences for ternary complex To determine whether myocardin interacted with the DNA binding or transcription activation domain of SRF, formation (see below).
The region of myocardin required for ternary complex we performed gel mobility shift assays with an SRF deletion mutant encompassing the MADS domain but formation with SRF was determined using myocardin deletion mutants. Deletion of the amino-terminal 140 lacking the amino and carboxyl termini. This SRF mutant (SRF 100-300) bound the CArG box sequence and amino acids (N⌬140) abolished association with SRF, as did larger amino-terminal deletions (Figures 6B and formed a ternary complex with myocardin ( Figure 6C ). Association of myocardin and SRF was also readily 6D). In contrast, deletions from amino acid 381 to the carboxyl terminus did not affect SRF interaction (mudetectable in coimmunoprecipitation assays of epitopetagged proteins. Interaction was dependent on the tants C⌬381 and C⌬585). Deletion of the Q-rich domain or the basic region also abolished ternary complex foramino-terminal region of myocardin, as demonstrated by the association of myocardin mutant C⌬585, but not mation, whereas mutation of the SAP domain (PSF mutant) did not. These findings are consistent with the N⌬585, with SRF ( Figures 6D and 6E Our results demonstrate that a dominant negative myappearance of the embryo and second by the wild-type ocardin mutant that can associate with SRF, but cannot expression of these markers in the somite myotomes activate transcription, specifically interferes with cardiowhich also received the C⌬585 transcript. Expression myocyte differentiation when expressed in the dorsalof troponin I, a heart-specific differentiation marker, was vegetal blastomere that gives rise to the cardiac lineage also inhibited by C⌬585 (data not shown). In addition, in Xenopus. Intriguingly, dominant negative myocardin expression of Nkx2.5 was severely reduced in C⌬585-did not inhibit skeletal muscle differentiation in the soinjected embryos. The overall morphology of the emmite myotomes, as assayed by expression of cardiac bryos expressing C⌬585 was normal, indicating that the ␣-actin and ␣-tropomyosin. These findings are consismutant did not affect general aspects of embryogenesis. tent with the lack of myocardin expression in the skeletal We attempted to rescue C⌬585-injected embryos by muscle lineage and suggest that other factors in skeletal injection of wild-type myocardin mRNA. However, overmuscle interfere with the dominant negative effects of expression of wild-type myocardin resulted in severe the myocardin mutant. The precise role of myocardin in morphologic abnormalities and embryonic lethality. vascular development remains to be determined. Expression of the C⌬585 mutant resulted in a doseThe finding that dominant negative myocardin inhibits dependent reduction in expression of cardiac markers, the expression of multiple cardiac structural genes, as such that approximately 90% of injected embryos exhibwell as Nkx2.5, which is normally expressed prior to ited a reduction or complete elimination of cardiac gene cardiomyocyte differentiation, suggests that myocardin expression on the injected side (Table 1 ). In contrast, plays an essential early role in the cardiac developdefects were observed in 5% or less of embryos injected mental pathway. The effects of dominant negative myowith the GFP marker alone. Together, these results demcardin in vivo suggest that this mutant sequesters SRF onstrate that dominant negative myocardin can specifiand prevents endogenous myocardin from forming a cally interfere with myocardial differentiation in vivo.
transcriptionally active complex. Accordingly, SRF is highly expressed in the early heart (Croissant et al., Discussion 1996). However, we cannot rule out the possibility that myocardin may have other partners in vivo that account Myocardin is a novel SRF cofactor with the following properties that implicate it in SRF-dependent activation for the inhibition of cardiac differentiation by this mutant.
Figure 7. Inhibition of Myocardial Gene Expression by Expression of Dominant Negative Myocardin in Xenopus Embryos
Xenopus embryos at the 8-cell stage were injected with mRNA encoding the C⌬585 mutant of myocardin and GFP or GFP alone (control) and were assayed for expression of (A) cardiac ␣-actin, (B) ␣-tropomyosin, or (C) Nkx2.5 at stage 28 by whole-mount in situ hybridization. (A, e-h), (B, c-d) , and (C) show ventral views; other panels show lateral views. The dotted line bisects the symmetrical heart-forming region. Arrowheads show the heart on the injected side, which displays a reduced level of expression of cardiac markers. cg, cement gland; h, heart; s, somites.
Previous studies showed that dominant negative or by interference with CArG box-dependent cardiac structural genes, or both. Nkx2.5 mutants were able to prevent cardiac development in injected Xenopus embryos (Fu et al., 1998; Grow and Krieg, 1998). Thus, because the dominant negative Coregulation of Muscle Gene Expression myocardin mutant interferes with Nkx2.5 expression, its by SRF and Myocardin effects could be mediated by downregulation of Nkx2.5
In contrast to the association of SRF with p62TCF, which requires contact of TCF with a specific DNA sequence flanking the CArG box (Shaw et al., 1989) , myocardin scriptional activation by SRF is extremely sensitive to SRF levels and that high amounts of SRF can inhibit mary function appears to be as a transcriptional activator because it contains a potent transcriptional activation doactivation by SRF, as well as other activators (Prywes and Zhu, 1992 appear to form stable DNA binding ternary complexes on the CArG box with Nkx2.5 or GATA4.
Generation of Myocardin Mutants
Myocardin expression plasmids were generated through conventional or PCR-based cloning. Site-directed mutagenesis was per- 
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